Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of fluocinolone acetonide intravitreal insert for chronic non-infectious posterior segment uveitis
ChiCTR1900026160Phase 3Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Oct 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluocinolone in non-infectious posterior uveitis (NIPU) and uveitis (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: Proportion of subjects with recurrence of uveitis in the study eye within 6 months after treatment. Started Oct 2019; status: recruiting.
02
Drugs
fluocinolone
03
Conditions
non-infectious posterior uveitis (NIPU)uveitis
Beyond the preview
Go deeper on ChiCTR1900026160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026160.